Investor mix
7 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Other / undisclosed | 4 | 57% |
Developer of therapeutics for the treatment of autoimmune diseases
7 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Other / undisclosed | 4 | 57% |